Thomas A. Dix

Halimed Pharmaceuticals, Inc.

$7,374,782

Attributed

$10,014,920

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY2010–19

$2M$1.5M$1M$500K$0

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

Funding mix

By agency

NIH$10,014,920 · 7

By mechanism

R44$7,082,041 · 3

R42$1,500,000 · 1

R41$883,728 · 1

R43$549,151 · 2

Top collaborators

Shan P Yu7 shared

Others in their field

Top investigators on “Pharmaceutical Preparations”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947

Research focus

Pharmaceutical PreparationsNeurotensin ReceptorsCollaborationsPre-ClinicalAnimalsClinical TrialsBaseRattusAgonistLeadBlood - Brain Barrier AnatomyAdverse EffectsBrainEvaluationPreparationProgramsPhase 1 StudyInvestigationToxic EffectPharmacologic SubstanceDrug DevelopmentPreclinical StudyNeurotensinDose